Spontaneous ADR reporting and drug safety signal induction in perspective: To honour Professor Jens Schou

Pharmacology and Toxicology, Supplement

Volumn 86, Issue 1, 2000, Pages 16-19

  Edwards, I Ralph ^a,b  

^a WHO Collaborating Ctr Intl Drug M   (Sweden)

^b UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; DATA BASE; DRUG INFORMATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; STANDARD;

EID: 0033948638     PISSN: 09019936     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0773.2000.d01-5.x     Document Type: Conference Paper

References (4)

1. CIOMS Working Group I. Guidelines for preparing core clinical safely information on drugs. WHO, Geneva, 1995.
2. CIOMS (editor): Guidelines for preparing core clinical safety information on drugs, 2nd. ed. World Health Organisation, Geneva, 1999.
3. CIOMS (editor): Benefit-risk balance for marketed drugs: evaluating safety signals. 1st. ed. World Health Organisation, Geneva, 1998.
4. Uppsala Monitoring Centre (editor): Effective communications in pharmacovigilance. 1st. ed. W. Lake Ltd., Birmingham, 1998.